Lactobacillus rhamnosus MP108
Product description
✅ Here are the key achievements of Lactobacillus rhamnosus MP108:
Read more
- EFSA-QPS System Permission
- Approved probiotic strain for Chinese food, including infant and children formulas
- Recognized as an approved food ingredient in Taiwan
- Validated through strict safety assessments: Acute Toxicity Test, Genetic Toxicity Test, 90-Day Oral Toxicity Test
- Clinically Proven
- Protected in 11 global patents, including USA, CN, TW
- Published in 9 international scientific papers (3 SCI Papers)
- Awarded in NutraIngredient Asia Award Finalist: Editors Award for Infant and Child Nutrition Initiative in 2021.
- Awarded in World Food Innovation Awards Finalist: Best Ingredient Innovation in 2021.
- Awarded in Nutrition & Functional Food Asia Pacific (NFFA) Infant Nutrition Ingredient Award in 2021.
Specifications
Categories | Anti-allergens; Clinical trials; Probiotics |
---|---|
Sales markets | Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Central/South America |
Supplied from | Taiwan, China |
Product Applications | Food Supplements; Infant Nutrition/ Baby Foods & Infant Formula; Natural Products |
Product Certifications | Gluten-free; Halal; Health & Safety (GMP, HAACP and equivalents); Health claims; Natural; Quality assurance; Sustainable; Traceable |
Lactobacillus rhamnosus MP108